HomeQuestion
Is there any data to quote possible benefit of endocrine therapy in an elderly woman with low risk breast cancer who is refusing primary surgical treatment?
1 Answers
Mednet Member
Medical Oncology · Icahn School of Medicine at Mount Sinai
Yes, there are primary neoadjuvant endocrine trial versus surgery in Cochrane review (Morgan et al., Surgery versus primary endocrine for operable primary breast cancer in elderly women (70 years old); Cochrane Database Syst Rev 2014;5:1-40). The randomized trials used tamoxifen. The bottom line is ...